Conclusions
Our review has demonstrated a non-significant rise in the frequency of IUD in the pandemic period in 2020 compared to those in 2019. Additionally, there was a significantly lower lymphocyte count during the pandemic period- a marker known to be associated with COVID-19. This acts as proof of concept and warrants ongoing investigation to explore the link between COVID-19 and disorders of poor placental perfusion, particularly the rates of IUD.